Predicting risk of major adverse cardiac events

Invention Grant

US09965593B2 Predicting risk of major adverse cardiac events 有权

Please log in to see more content

Patent Title: Predicting risk of major adverse cardiac events
Application No.: US14244526

Application Date: 2014-04-03
Publication No.: US09965593B2

Publication Date: 2018-05-08
Inventor: James V. Snider , Eugene R. Heyman
Applicant: Critical Care Diagnostics, Inc.
Applicant Address: US CA San Diego
Assignee: Critical Care Diagnostics, Inc.
Current Assignee: Critical Care Diagnostics, Inc.
Current Assignee Address: US CA San Diego
Agency: Fish & Richardson P.C.
Main IPC: G06F19/20
IPC: G06F19/20 ; G06F19/00 ; C12Q1/68 ; G01N33/68 ; G01N33/74

Predicting risk of major adverse cardiac events

Abstract:

Measurement of circulating ST2 and natriuretic peptide (e.g., NT-proBNP) concentrations is useful for the prognostic evaluation of subjects, in particular for the prediction of adverse clinical outcomes, e.g., mortality, transplantation, and heart failure.

Public/Granted literature

US20150081224A1 PREDICTING RISK OF MAJOR ADVERSE CARDIAC EVENTS Public/Granted day:2015-03-19

Information query

Espacenet